Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The Federal Trade Commission has accused PBMs of driving independent pharmacists out of business
Accessed June 25, 2023, Centers for Disease Control and Prevention
The active ingredient in compounded semaglutide is the same molecule that Novo Nordisk sells as Wegovy (FDA-approved for chronic weight management) and Ozempic (FDA-approved for type 2 diabetes, prescribed off-label for weight loss)
Researchers often seek information about side effects because understanding the safety profile of any compound is an important part of scientific evaluation
Reported effects, mostly anecdotal from the research community, include injection site redness or minor swelling, transient fatigue in the first week of loading, and mild headache when doses are pushed above the typical research range
